Your browser doesn't support javascript.
loading
Quality comparability assessment of a SARS-CoV-2-neutralizing antibody across transient, mini-pool-derived and single-clone CHO cells.
Xu, Gangling; Yu, Chuanfei; Wang, Wenbo; Fu, Cexiong; Liu, Hongchuan; Zhu, Yanping; Li, Yuan; Liu, Chunyu; Fu, Zhihao; Wu, Gang; Li, Meng; Guo, Sha; Yu, Xiaojuan; Du, Jialiang; Yang, Yalan; Duan, Maoqin; Cui, Yongfei; Feng, Hui; Wang, Lan.
  • Xu G; Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products, China National Institutes for Food and Drug Control, Beijing, China.
  • Yu C; Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products, China National Institutes for Food and Drug Control, Beijing, China.
  • Wang W; Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products, China National Institutes for Food and Drug Control, Beijing, China.
  • Fu C; Shanghai Junshi Biosciences Co. Ltd, Shanghai, China.
  • Liu H; Shanghai Junshi Biosciences Co. Ltd, Shanghai, China.
  • Zhu Y; Shanghai Junshi Biosciences Co. Ltd, Shanghai, China.
  • Li Y; Shanghai Junshi Biosciences Co. Ltd, Shanghai, China.
  • Liu C; Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products, China National Institutes for Food and Drug Control, Beijing, China.
  • Fu Z; Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products, China National Institutes for Food and Drug Control, Beijing, China.
  • Wu G; Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products, China National Institutes for Food and Drug Control, Beijing, China.
  • Li M; Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products, China National Institutes for Food and Drug Control, Beijing, China.
  • Guo S; Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products, China National Institutes for Food and Drug Control, Beijing, China.
  • Yu X; Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products, China National Institutes for Food and Drug Control, Beijing, China.
  • Du J; Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products, China National Institutes for Food and Drug Control, Beijing, China.
  • Yang Y; Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products, China National Institutes for Food and Drug Control, Beijing, China.
  • Duan M; Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products, China National Institutes for Food and Drug Control, Beijing, China.
  • Cui Y; Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products, China National Institutes for Food and Drug Control, Beijing, China.
  • Feng H; Shanghai Junshi Biosciences Co. Ltd, Shanghai, China.
  • Wang L; Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products, China National Institutes for Food and Drug Control, Beijing, China.
MAbs ; 14(1): 2005507, 2022.
Article en En | MEDLINE | ID: mdl-34923915

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Anticuerpos Neutralizantes / Glicoproteína de la Espiga del Coronavirus / SARS-CoV-2 / COVID-19 / Anticuerpos Monoclonales / Anticuerpos Antivirales Límite: Animals / Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Anticuerpos Neutralizantes / Glicoproteína de la Espiga del Coronavirus / SARS-CoV-2 / COVID-19 / Anticuerpos Monoclonales / Anticuerpos Antivirales Límite: Animals / Humans Idioma: En Año: 2022 Tipo del documento: Article